LTRN
Lantern Pharma Inc
1.20$
-12.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.3% | 99.3% | 99.3% | 99.2% | 98.8% | 98.7% | 98.7% | 98.7% | 98.8% | 97.9% | 97.7% | 98.3% | |
| 53.5% | 50.3% | 46.2% | 36.5% | 26.7% | 29.4% | 30.2% | 34.8% | 61.6% | 40.1% | 68.1% | 77.4% | |
| 94.0% | 94.6% | 96.5% | 93.5% | 92.6% | 93.9% | 93.5% | 91.3% | 90.7% | 91.7% | 87.5% | 85.6% | |
| – | 2.0% | – | – | – | 0.4% | – | – | – | – | – | – | |
| 4.9% | 6.3% | 10.0% | 13.1% | 12.2% | 17.1% | 20.5% | 28.1% | 29.6% | 40.8% | 52.3% | 137.4% | |
| 4.7% | 6.1% | 9.9% | 12.9% | 11.9% | 16.9% | 20.3% | 28.0% | 29.6% | 40.8% | 52.3% | 50.2% | |
| 0.4% | 0.4% | 0.4% | 0.5% | 0.7% | 0.7% | 0.8% | 0.8% | 0.7% | 0.7% | 0.8% | 0.5% | |
| 4.4% | 2.2% | 4.1% | 12.5% | 11.2% | 16.2% | 19.6% | 27.3% | 29.0% | – | 51.5% | – | |
| 95.1% | 93.7% | 90.0% | 86.9% | 87.8% | 82.9% | 79.5% | 71.9% | 70.4% | 59.2% | 47.7% | -37.4% | |
| -106.9% | -126.6% | -152.7% | -184.5% | -231.6% | -297.3% | -381.9% | -487.3% | -653.6% | -844.0% | -1,335.6% | -1,203.7% | |
| 22.7% | 24.7% | 27.0% | 30.2% | 35.5% | 42.2% | 51.1% | 61.9% | 79.5% | 98.8% | 155.8% | 144.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.